{
    "title": "Arthritis drug improves survival odds for COVID-19 patients treated with remdesivir by 35%, NIH study finds",
    "url": "https://www.dailymail.co.uk/health/article-8820367/Lillys-rheumatoid-arthritis-drug-cuts-COVID-19-deaths-trial-data-shows.html",
    "date": "2020-10-08",
    "keywords": [
        "remdesivir",
        "drug",
        "barcitinib",
        "covid19",
        "percent",
        "combination",
        "arthritis",
        "oxygen",
        "recovery",
        "emergency",
        "death",
        "coronavirus",
        "nih",
        "study",
        "condition",
        "use",
        "authorization",
        "addition",
        "trial",
        "approval",
        "time",
        "share",
        "response",
        "top",
        "maker",
        "institutes",
        "health",
        "board",
        "treatment",
        "regimen",
        "survival",
        "risk",
        "average",
        "supply",
        "brand",
        "name",
        "olumiant",
        "dr",
        "anthony",
        "fauci",
        "institute",
        "allergy",
        "life",
        "antiviral",
        "first",
        "president",
        "trump",
        "steroid",
        "antibody",
        "cocktail",
        "sarscov2",
        "virus",
        "body",
        "article",
        "infection",
        "inflammation",
        "bodys",
        "haywire",
        "invader",
        "corp",
        "cytokine",
        "storm",
        "autoimmune",
        "candidate",
        "placebo",
        "effect",
        "therapy",
        "effectiveness",
        "baricitinib",
        "deathin",
        "group",
        "reduction",
        "september",
        "day",
        "studys",
        "fda"
    ],
    "category": [
        "health"
    ]
}